Contact: Vicki Cohn, (914) 740-2156, firstname.lastname@example.org
Integrated Approaches to Customize Fungal Cell Factories Described in Industrial Biotechnology Journal
New Rochelle, NY, December 19, 2013—The natural ability of certain fungi to break down complex substances makes them very valuable microorganisms to use as cell factories in industrial processes. Advances in metabolic engineering and systems biology are helping to customize and optimize these fungi to produce specific bioproducts, as described in a Review article in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Industrial Biotechnology website.
In the Review “Integrated Approaches for Assessment of Cellular Performance in Industrially Relevant Filamentous Fungi,” Mhairi Workman, Mikael Anderson, and Jette Thykaer, Technical University of Denmark, Lyngby, focus on how to apply state-of-the-art analytical tools and technologies to characterize industrially relevant fungi, improve fungal cell factories, and “utilize fungal bioproduct diversity to its full potential.”
The Review is part of an IB IN DEPTH special section on Fungal Biology led by Guest Editors Scott Baker, PhD, Pacific Northwest National Laboratory (PNNL), Richland, WA, and Adrian Tsang, PhD, Concordia University, Montreal, Canada. Additional Original Research articles include “Kinetic Modeling of β-Glucosidases and Cellobiohydrolases Involved in Enzymatic Hydrolysis of Cellulose,” by Marie Chauve, PhD, et al. from IFP Energies nouvelles (Solaize and Rueil-Malmaison, France), European Synchrotron Radiation Facility and Centre de Recherches sur les Macromolecules Vegétales (Grenoble, France); and “Comparative Genomics Analysis of Trichoderma reesei Strains,” by Hideaki Koike, PhD, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan, and colleagues from the US Department of Energy (DOE) Joint Genome Institute (Walnut Creek, CA), and PNNL.
Also included in the Fungal Biology special section are two IB Interviews: with Randy Berka of Novozymes (Davis, CA); and Igor Grigoriev, PhD, US DOE Joint Genome Institute.
"Once again, one of IB's Editorial Board members has stepped forward to tell a compelling story of industrial biotechnology development," says Co-Editor-in-Chief Larry Walker, PhD, Professor, Biological & Environmental Engineering, Cornell University, Ithaca, NY. "The opportunities to exploit fungal biotechnology for industrial chemicals and energy are unlimited."
About the Journal
Industrial Biotechnology, led by Co-Editors-in-Chief Larry Walker, PhD, and Glenn Nedwin, PhD, MoT, is an authoritative journal focused on biobased industrial and environmental products and processes, published bimonthly in print and online. The Journal reports on the science, business, and policy developments of the emerging global bioeconomy, including biobased production of energy and fuels, chemicals, materials, and consumer goods. The articles published include critically reviewed original research in all related sciences (biology, biochemistry, chemical and process engineering, agriculture), in addition to expert commentary on current policy, funding, markets, business, legal issues, and science trends. Industrial Biotechnology offers the premier forum bridging basic research and R&D with later-stage commercialization for sustainable biobased industrial and environmental applications.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in promising areas of science and biomedical research, including Environmental Engineering Science and Sustainability: The Journal of Record. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.